148 related articles for article (PubMed ID: 32722616)
1. The Feasibility of Host Transcriptome Profiling as a Diagnostic Tool for Microbial Etiology in Childhood Cancer Patients with Febrile Neutropenia.
Wahlund M; Sinha I; Broliden K; Saghafian-Hedengren S; Nilsson A; Berggren A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722616
[TBL] [Abstract][Full Text] [Related]
2. Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia.
Haeusler GM; Garnham AL; Li-Wai-Suen CS; Clark JE; Babl FE; Allaway Z; Slavin MA; Mechinaud F; Smyth GK; Phillips B; Thursky KA; Pellegrini M; Doerflinger M
Clin Transl Immunology; 2022; 11(5):e1383. PubMed ID: 35602885
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer.
Tapia LI; Olivares M; Torres JP; De la Maza V; Valenzuela R; Contardo V; Tordecilla J; Álvarez AM; Varas M; Zubieta M; Salgado C; Venegas M; Gutiérrez V; Claverie X; Villarroel M; Santolaya ME
Cytokine; 2021 Dec; 148():155619. PubMed ID: 34134910
[TBL] [Abstract][Full Text] [Related]
5. Mannose binding lectin and ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia.
Pana ZD; Samarah F; Papi R; Antachopoulos C; Papageorgiou T; Farmaki E; Hatzipantelis E; Tragiannidis A; Vavatsi-Christaki N; Kyriakidis D; Athanassiadou-Piperopoulou F; Roilides E
Pediatr Blood Cancer; 2014 Jun; 61(6):1017-22. PubMed ID: 24453114
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia.
Meena JP; Brijwal M; Seth R; Gupta AK; Jethani J; Kapil A; Jat KR; Choudhary A; Kabra SK; Dwivedi SN; Dar L
Pediatr Hematol Oncol; 2019 Sep; 36(6):330-343. PubMed ID: 31512959
[No Abstract] [Full Text] [Related]
7. A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Sarashina T; Kobayashi R; Yoshida M; Toriumi N; Suzuki D; Sano H; Azuma H
Pediatr Blood Cancer; 2014 Nov; 61(11):1992-5. PubMed ID: 25130289
[TBL] [Abstract][Full Text] [Related]
8. Clinical Profile and Microbiologic Spectrum of Febrile Neutropenic Episodes in Children With Severe Aplastic Anemia.
Samanta A; Chandra J; Kaur R; Anand R; Shukla S; Mandal P
J Pediatr Hematol Oncol; 2020 Apr; 42(3):193-197. PubMed ID: 32209945
[TBL] [Abstract][Full Text] [Related]
9. A Protocol for Low-Input RNA-Sequencing of Patients with Febrile Neutropenia Captures Relevant Immunological Information.
Probst V; Smedegaard LM; Simonyan A; Guo Y; Østrup O; Dungu KHS; Vissing NH; Nygaard U; Bagger FO
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373397
[TBL] [Abstract][Full Text] [Related]
10. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
[TBL] [Abstract][Full Text] [Related]
13. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study.
Söderman M; Rhedin S; Tolfvenstam T; Rotzén-Östlund M; Albert J; Broliden K; Lindblom A
PLoS One; 2016; 11(6):e0157398. PubMed ID: 27309354
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
Whittle SB; Williamson KC; Russell HV
Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
[TBL] [Abstract][Full Text] [Related]
16. Effects of respiratory viruses on febrile neutropenia attacks in children.
Aldemir-Kocabaş B; Karbuz A; Pekpak E; Karahan ZC; Dolapçı İ; İnce E; Uysal Z; Yavuz G; Çiftçi E; İnce E
Turk J Pediatr; 2017; 59(5):511-519. PubMed ID: 29745111
[TBL] [Abstract][Full Text] [Related]
17. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia.
Torres JP; Labraña Y; Ibañez C; Kasaneva P; Farfán MJ; De la Maza V; Villarroel M; Vergara I; Piemonte P; Zubieta M; Salgado C; Tordecilla J; Topelberg S; O Ryan M; Santolaya ME
Pediatr Infect Dis J; 2012 Sep; 31(9):889-93. PubMed ID: 22565292
[TBL] [Abstract][Full Text] [Related]
18. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up.
Alexandropoulou O; Kossiva L; Haliotis F; Giannaki M; Tsolia M; Panagiotou IP; Karavanaki K
Eur J Pediatr; 2013 Jun; 172(6):811-9. PubMed ID: 23408310
[TBL] [Abstract][Full Text] [Related]
19. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.
Delebarre M; Dessein R; Lagrée M; Mazingue F; Sudour-Bonnange H; Martinot A; Dubos F
J Infect; 2019 Aug; 79(2):95-100. PubMed ID: 31228471
[TBL] [Abstract][Full Text] [Related]
20. Mannose-binding lectin genotype influences frequency and duration of infectious complications in children with malignancy.
Dommett R; Chisholm J; Turner M; Bajaj-Elliott M; Klein NJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):69-75. PubMed ID: 23073041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
